Bladder Cancer Updates & SC Amivantamab

Are we nearing the end of the Platinum Era in bladder cancer? A press release suggests enfortumab vedotin + pembrolizumab in a perioperative approach is better than the current standard of care: neoadjuvant cisplatin-based chemo followed by surgery. We eagerly await seeing this data. Also, a subcutaneous amivantamab/hyaluronidase formulation is approved, which offers a much lower risk of infusion reactions - but some chances for dosing errors based on weights and available dosage forms.

You can listen to Bladder Cancer Updates & SC Amivantamab online on Radio and Podcast. Open the player on this page to stream the available audio.

Bladder Cancer Updates & SC Amivantamab is an episode from OncoPharm by OncoPharmPod.

This episode is 00:13:03 long.

This episode was published on Dec 18, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from OncoPharm when more episodes are available from the podcast feed.